吲哚菁绿血管造影预测高压氧治疗糖尿病足溃疡的灌注反应与愈合
慢性伤口患者治疗后灌注显著增加(p < 0.03),且第1至第2次治疗间灌注改善者100%在高压氧完成30天内愈合,无改善者无一愈合(p < 0.01)。提示吲哚菁绿血管造影可作为早期预测高压氧治疗反应的生物标志物。
要点
- 高压氧治疗可显著改善慢性伤口灌注(p < 0.03)。
- 第1至第2次治疗间灌注改善预测30天内愈合(p < 0.01)。
- 吲哚菁绿血管造影或可用于早期筛选高压氧获益人群。
核心结论
- 高压氧治疗通过改善缺氧和促进血管生成改善慢性伤口灌注。
- 吲哚菁绿血管造影可能用于早期识别最可能从高压氧治疗中获益的患者。
研究设计与样本
- 慢性伤口患者接受30至40次连续高压氧治疗,每天1次,每周5天;对照接受2次连续治疗。
- 治疗前后行吲哚菁绿血管造影并分析灌注模式,临床判定愈合。
主要发现
- 慢性伤口患者高压氧治疗后吲哚菁绿血管造影灌注显著增加(p < 0.03),健康对照无此变化。
- 第1至第2次治疗间灌注改善的伤口100%在高压氧完成30天内愈合,无改善亚组无一愈合(p < 0.01)。
关键数值与推荐
- 纳入标准为成人仅有单个活动性Wagner III级糖尿病足溃疡或软组织放射性坏死所致慢性伤口。
- 愈合定义为全层皮肤上皮化且无临床伤口渗液证据。
- 证据等级为治疗性IV级。
临床怎么用
- 可考虑用吲哚菁绿血管造影在高压氧治疗早期(第1至第2次间)评估灌注改善以预测愈合。
- 对灌注无改善者需重新评估高压氧治疗获益并调整方案。
局限性
- 证据等级为IV级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
SUMMARY: The authors present indocyanine green angiography to assess the effects of hyperbaric oxygen therapy and as a potential biomarker to predict healing of chronic wounds. They hypothesize that favorable initial response to hyperbaric oxygen therapy (improved perfusion) would be an early indicator of eventual response to the treatment (wound healing). Two groups were recruited: patients with chronic wounds and unwounded healthy controls. Inclusion criteria included adults with only one active wound of Wagner grade III diabetic foot ulcer or caused by soft-tissue radionecrosis. Patients with chronic wounds underwent 30 to 40 consecutive hyperbaric oxygen therapy sessions, once per day, 5 days per week; controls underwent two consecutive sessions. Indocyanine green angiography was performed before and after the sessions, and perfusion patterns were analyzed. Healing was determined clinically and defined as full skin epithelialization with no clinical evidence of wound drainage. Fourteen chronic-wound patients and 10 controls were enrolled. Unlike unwounded healthy volunteers, a significant increase in indocyanine green angiography perfusion was found in chronic-wound patients immediately after therapy (p < 0.03). Moreover, the authors found that 100 percent of the wounds that demonstrated improved perfusion from session 1 to session 2 went on to heal within 30 days of hyperbaric oxygen therapy completion, compared with none in the subgroup that did not demonstrate improved perfusion (p < 0.01). This study demonstrates a beneficial impact of hyperbaric oxygen therapy on perfusion in chronic wounds by ameliorating hypoxia and improving angiogenesis, and also proposes a potential role for indocyanine green angiography in early identification of those who would benefit the most from hyperbaric oxygen therapy. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
引用
- Hajhosseini B, Chiou GJ, Virk SS, et al. Hyperbaric Oxygen Therapy in Management of Diabetic Foot Ulcers: Indocyanine Green Angiography May Be Used as a Biomarker to Analyze Perfusion and Predict Response to Treatment. Plast Reconstr Surg. 2021. PMID: 33370067. doi:10.1097/PRS.0000000000007482
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。